Article
A Comprehensive Workflow for Plasma Proteomics by Mass Spectrometry: A Strategy for Biomarker Discovery in Systemic Human Diseases.
Research record from J Vis Exp, 2026-03-13. PMID 41911173.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Article
Research record from J Vis Exp, 2026-03-13. PMID 41911173.
Article
Research record from Brain Res, 2026-03-10. PMID 41819517.
Article
Research record from J Sep Sci, 2026-04-01. PMID 42013006.
Article
Research record from Clin Chem Lab Med, 2026-08-12. PMID 42578267.
Article
Research record from Cell Rep Methods, 2026-05-07. PMID 42102803.
Article
Research record from Anal Sci Adv, 2026-04-06. PMID 41947975.
Article
Research record from Alzheimers Res Ther, 2026-10-24. PMID 42958309.
Article
Research record from Blood Cancer J, 2026-03-28. PMID 41904132.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.